Tempus AI stock price has rebounded this year as demand for artificial intelligence solutions jumped sharply. The TEM stock ...

We recently compiled a list of the 10 Firms Shine Amid Market Slump. In this article, we are going to take a look at where ...

Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing.

The more significant driver of Tempus’ rally was the announcement of its new AI-enabled health app, Olivia. Designed as a personal health concierge, Olivia integrates patient data from over ...

Tempus AI has launched olivia in the US, an app designed for centralising patient healthcare data onto a unified platform that uses AI to provide actionable insights. Patients can use the app to ...

Tempus AI shares surged more than 35% on Tuesday after former House Speaker Nancy Pelosi disclosed call options expiring in 2026. Several AI-related stocks are rising Wednesday after U.S ...

Tempus AI stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge and former House Speaker Nancy Pelosi revealed she's bet on the stock.

Tempus Ai got a big valuation boost following a disclosure that Nancy Pelosi had purchased call options for the stock. The healthcare AI company also unveiled its new software service today.

Tempus Ai (NASDAQ: TEM) stock is seeing an explosive valuation surge in Tuesday's trading thanks to a pair of catalysts. The healthcare software company's share price was up 35.8% as of 3:15 p.m ...

Tempus AI was one of them. Pelosi purchased 50 call options with a strike price of $20 that also expire on Jan. 16, 2026. The value of the trade was between $50,000 and $100,000.